All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @thetrailtohealth on Instagram · 60s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @thetrailtohealth's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What's kind of the differences between the two, what's going on in your body, and what age do you usually start to notice some of those changes?
  2. 0:06Yeah, great question. So semantics, in terms of what is perimenopause, it's everything that leads up to menopause.
  3. 0:13And menopause is one single day. So menopause is the 12 month anniversary of your last period.
  4. 0:23So it's when you've been without a period for 12 months, that is your day of menopause, and then everything after that is postmenopause.
  5. 0:31And so the symptoms that a woman experiences prior to menopause are called perimenopause.
  6. 0:36And it depends on the woman, but it can last up to 10 years before menopause.
  7. 0:40Yeah, exactly. Most women are experiencing changes around their mid-40s, but we can experience more subtle changes earlier on.
  8. 0:52So even in your late 30s, sometimes women will experience like sleep changes, mild changes before any cycle changes begin.

@thetrailtohealth's hormone therapy claims, fact-checked

Erika Schlick | Health Coach, Blogger & Author

Instagram creator

6.0K viewsView on Instagram

Quick answer

The video accurately defines menopause using the standard 12-month amenorrhea criterion and correctly positions perimenopause as the symptomatic transition preceding it. The claim that perimenopause can last up to 10 years reflects the upper range seen in longitudinal cohort data, though the population median is closer to 4 to 7 years. The suggestion that hormonal symptoms can begin in the late 30s is biologically plausible but clinically imprecise, as late-30s symptoms overlap significantly with non-hormonal causes and require proper differential diagnosis before attributing them to ovarian decline.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @thetrailtohealth's hormone therapy claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@thetrailtohealth's hormone therapy claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@thetrailtohealth's hormone therapy claims, fact-checked" from Erika Schlick | Health Coach, Blogger & Author. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video accurately defines menopause using the standard 12-month amenorrhea criterion and correctly positions perimenopause as the symptomatic transition preceding it.

The reason this review is not generic is the source wording and the canonical claim label "trt episode 70 of thishealthylifepodcast is live if you." In this clip, the useful excerpt is: "What's kind of the differences between the two, what's going on in your body, and what age do you usually start to notice some of those changes?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

SWAN cohort data (Harlow et al.
People who land here are usually comparing the Testosterone claim with ThisHealthyLifePodcast, ThisHealthyLife, and TheTrailToHealth.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video accurately defines menopause using the standard 12-month amenorrhea criterion and correctly positions perimenopause as the symptomatic transition preceding it.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video accurately defines menopause using the standard 12-month amenorrhea criterion and correctly positions perimenopause as the symptomatic transition preceding it. The claim that perimenopause can last up to 10 years reflects the upper range seen in longitudinal cohort data, though the population median is closer to 4 to 7 years. The suggestion that hormonal symptoms can begin in the late 30s is biologically plausible but clinically imprecise, as late-30s symptoms overlap significantly with non-hormonal causes and require proper differential diagnosis before attributing them to ovarian decline.
  • Menopause is defined as 12 consecutive months without a period, per Endocrine Society and Menopause Society guidelines, making it a retrospective diagnosis, not something identified in real time.
  • SWAN cohort data (Harlow et al., 2012) shows the menopausal transition averages 4 to 8 years for most women, not 10; the 10-year figure represents the upper range, not the typical experience.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Menopause is defined as 12 consecutive months without a period, per Endocrine Society and Menopause Society guidelines, making it a retrospective diagnosis, not something identified in real time.
  • SWAN cohort data (Harlow et al., 2012) shows the menopausal transition averages 4 to 8 years for most women, not 10; the 10-year figure represents the upper range, not the typical experience.
  • Santoro et al. (2021, Journal of Clinical Endocrinology and Metabolism) found perimenopause duration ranges from 1 to 13 years, with wide individual variability based on genetics, ethnicity, and BMI.
  • Late-30s symptoms like sleep disruption overlap heavily with thyroid dysfunction, anxiety, and sleep apnea. Attributing them to perimenopause without a workup is a diagnostic shortcut that can lead to missed diagnoses.
  • Premature ovarian insufficiency (POI) affects roughly 1 in 100 women under 40 and requires different clinical management than typical perimenopause; women under 40 with cycle changes should see a physician promptly.
  • The Menopause Society recommends against initiating hormone therapy based on symptoms alone; FSH, estradiol, and AMH levels combined with cycle history are part of appropriate clinical evaluation.
  • Perimenopause remains a clinical diagnosis. No single lab value confirms it, and self-diagnosis from wellness content, even accurate wellness content, is not a substitute for evaluation by a licensed clinician.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @thetrailtohealth actually say?

The video features Dr. Mary Pardee, a naturopathic doctor, breaking down the difference between perimenopause, menopause, and postmenopause. The core claims: menopause is defined as "the 12 month anniversary of your last period," perimenopause is everything leading up to that point, it "can last up to 10 years before menopause," and women may start noticing changes in their "late 30s" including "sleep changes, mild changes before any cycle changes begin."

These are fairly specific clinical statements, not vague wellness talking points. That makes them checkable. So let's check them.

Does the science back this up?

Mostly, yes. The definitions here are accurate, and the timeline claims are well within the range supported by research. The 12-month amenorrhea threshold for menopause is the standard clinical definition used by the Endocrine Society and NAMS. The claim that perimenopause can last up to 10 years is supported by population data.

The Study of Women's Health Across the Nation (SWAN), which has followed over 3,000 women across multiple ethnic groups since 1996, found that the menopausal transition averages around 4 to 8 years but can extend longer in some women (Harlow et al., 2012, Menopause). A 2021 review in the Journal of Clinical Endocrinology and Metabolism confirmed perimenopause duration ranges widely, from 1 to 13 years, with a median closer to 4 years (Santoro et al., 2021). So "up to 10 years" is accurate as an upper range, though it describes a minority of women, not the typical experience.

The late-30s onset claim is more nuanced. Research does support that hormonal fluctuations, particularly in anti-Mullerian hormone (AMH), can begin in the late 30s, but symptomatic perimenopause typically starts in the mid-40s. Saying late-30s changes are "subtle" is a fair qualifier.

What did they get wrong (or right)?

They got the definitions right. The "12 month anniversary" framing is a little casual, but clinically it is accurate. The 10-year upper limit is real, but presenting it without noting the median duration could give viewers the impression that decade-long perimenopause is common. It is not. Most women are looking at 4 to 7 years.

The late-30s symptom claim is where things get a little slippery. The sleep and mood changes that some women notice in their late 30s are not always attributable to ovarian hormone shifts. Research from the SWAN cohort shows irregular cycles, the hallmark of perimenopause, typically begin in the mid-to-late 40s for most women (Avis et al., 2015, JAMA Internal Medicine). Attributing late-30s sleep disruption to hormonal perimenopause, rather than to stress, poor sleep hygiene, thyroid changes, or other causes, requires more diagnostic precision than this video offers. The claim is not wrong, but it is vague enough to be misleading for someone self-diagnosing.

Credit where it is due: the postmenopause distinction is often skipped in wellness content. Mentioning it here is accurate and useful.

What should you actually know?

Perimenopause is a real, clinically recognized transition, not a wellness buzzword. The definitions used in this video are largely sound. But the range of 10 years and the late-30s onset framing can feed a pattern that reproductive medicine physicians are increasingly worried about: women in their late 30s seeking hormone therapy based on nonspecific symptoms like fatigue or sleep problems, which may have nothing to do with ovarian decline.

The Menopause Society and the American College of Obstetricians and Gynecologists recommend against initiating hormone therapy based on symptoms alone without appropriate lab work and clinical evaluation. AMH, FSH, and estradiol levels, along with cycle history, are part of a proper workup. Self-diagnosing perimenopause from a podcast is not a workup.

  • If you are under 40 and experiencing what feels like perimenopause symptoms, see a physician. Premature ovarian insufficiency (POI) affects about 1 in 100 women under 40 and requires different clinical management than typical perimenopause.
  • Sleep changes in the late 30s have multiple causes. Do not assume hormones without ruling out thyroid dysfunction, mood disorders, and sleep apnea first.
  • Perimenopause diagnosis remains clinical, meaning based on symptoms and cycle changes, not a single lab value.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Erika Schlick | Health Coach, Blogger & Author · Instagram creator

6.0K views on this video

🎙 Episode 70 of @thishealthylifepodcast is LIVE!⁠ ⁠ If you’re navigating hormonal shifts or wondering whether HRT is right for you, this episode is essential listening.⁠ ⁠ I’m joined by Dr. Mary Pard

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about menopause?

Menopause is defined as 12 consecutive months without a period, per Endocrine Society and Menopause Society guidelines, making it a retrospective diagnosis, not something identified in real time.

What does the video say about swan cohort data (harlow et al., 2012) shows the menopausal?

SWAN cohort data (Harlow et al., 2012) shows the menopausal transition averages 4 to 8 years for most women, not 10; the 10-year figure represents the upper range, not the typical experience.

What does the video say about santoro et al. (2021, journal of clinical endocrinology?

Santoro et al. (2021, Journal of Clinical Endocrinology and Metabolism) found perimenopause duration ranges from 1 to 13 years, with wide individual variability based on genetics, ethnicity, and BMI.

What does the video say about late-30s symptoms like sleep disruption overlap heavily with thyroid dysfunction,?

Late-30s symptoms like sleep disruption overlap heavily with thyroid dysfunction, anxiety, and sleep apnea. Attributing them to perimenopause without a workup is a diagnostic shortcut that can lead to missed diagnoses.

What does the video say about premature ovarian insufficiency (poi) affects roughly 1 in 100 women?

Premature ovarian insufficiency (POI) affects roughly 1 in 100 women under 40 and requires different clinical management than typical perimenopause; women under 40 with cycle changes should see a physician promptly.

What does the video say about the menopause society recommends against initiating hormone therapy based on?

The Menopause Society recommends against initiating hormone therapy based on symptoms alone; FSH, estradiol, and AMH levels combined with cycle history are part of appropriate clinical evaluation.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Erika Schlick | Health Coach, Blogger & Author, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.